GLTO Galecto Inc

Price (delayed)

$0.7001

Market cap

$18.98M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.14

Enterprise value

-$2.11M

Galecto is a clinical stage biotechnology company committed to the development of novel small molecule therapeutics directed at biological targets which are at the heart of fibrosis, inflammation, and cancer. ...

Highlights

Galecto's debt has plunged by 100% from the previous quarter and by 100% YoY

The quick ratio has soared by 66% YoY and by 11% from the previous quarter

GLTO's equity is down by 44% year-on-year and by 13% since the previous quarter

Sector: Healthcare

Industry: Biotechnology

Website: http://galecto.com

Peers: OMER OMGA

Key stats

What are the main financial stats of GLTO

Market

Shares outstanding

27.11M

Market cap

$18.98M

Enterprise value

-$2.11M

Valuations

Price to earnings (P/E)

N/A

Price to book (P/B)

0.67

Price to sales (P/S)

N/A

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

N/A

Earnings

Revenue

EBIT

-$30.83M

EBITDA

-$30.04M

Free cash flow

-$33.63M

Per share

EPS

-$1.14

Free cash flow per share

-$1.24

Book value per share

$1.04

Revenue per share

TBVPS

$1.2

Balance sheet

Total assets

$32.48M

Total liabilities

$4.32M

Debt

Equity

$28.16M

Working capital

$26.22M

Liquidity

Debt to equity

Current ratio

7.07

Quick ratio

6.29

Net debt/EBITDA

0.7

Margins

EBITDA margin

N/A

Gross margin

N/A

Net margin

N/A

Operating margin

N/A

Efficiency

Return on assets

-68.7%

Return on equity

-87.1%

Return on invested capital

-229.4%

Return on capital employed

-109.5%

Return on sales

N/A

Dividend

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

GLTO stock price

How has the Galecto stock price performed over time

Intraday

-1.39%

1 week

0.01%

1 month

-6.04%

1 year

-59.76%

YTD

-2.76%

QTD

-10.24%

Financial performance

How have Galecto's revenue and profit performed over time

Revenue

Gross profit

Operating income

-$32.15M

Net income

-$30.83M

Gross margin

N/A

Net margin

N/A

GLTO's net income is up by 47% year-on-year and by 20% since the previous quarter

The company's operating income rose by 44% YoY and by 19% QoQ

Growth

What is Galecto's growth rate over time

Valuation

What is Galecto stock price valuation

P/E

N/A

P/B

0.67

P/S

N/A

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

N/A

GLTO's EPS is up by 50% year-on-year and by 21% since the previous quarter

GLTO's equity is down by 44% year-on-year and by 13% since the previous quarter

GLTO's price to book (P/B) is 16% less than its last 4 quarters average of 0.8

Efficiency

How efficient is Galecto business performance

The company's return on invested capital has shrunk by 56% YoY and by 8% QoQ

The return on assets has increased by 7% year-on-year and by 5% since the previous quarter

Galecto's ROE has increased by 7% from the previous quarter

Dividends

What is GLTO's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for GLTO.

Financial health

How did Galecto financials performed over time

The current ratio has soared by 74% YoY and by 12% QoQ

Galecto's total liabilities has plunged by 70% YoY and by 27% from the previous quarter

Galecto's debt is 100% less than its equity

Galecto's debt has plunged by 100% from the previous quarter and by 100% YoY

GLTO's equity is down by 44% year-on-year and by 13% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.